$14.81
-0.03 (-0.20%)
As of Nov 12, 5:00 PM ET ·
RDY vs Pharmaceuticals Average
P/E Ratio
RDY 18.2
Avg 53.0
Profit Margin
RDY 17.3%
Avg -291.0%
Rev Growth
RDY +14.9%
Avg +17.8%
Div Yield
RDY 0.66%
Avg 3.30%

Pharmaceuticals Peers

1013 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
RDY Dr. Reddy's Laboratories $14.81 -0.20% 1.01T 18.2 17.3% +14.9% 0.66% Current
LLY Eli Lilly and Co. $1,382.75 -2.32% 1.34T 48.7 31.7% +31.7% 0.75% Strong buy Compare
JNJ Johnson & Johnson $272.70 -2.15% 692.05B 43.0 28.5% +5.6% 3.12% Buy Compare
MRK Merck & Co. Inc. $137.78 -3.90% 362.27B 147.7 28.1% +3.1% 2.87% Buy Compare
PFE Pfizer Inc. $28.06 -1.44% 164.04B 40.7 12.4% -14.8% 5.38% Hold Compare
BMY Bristol-Myers Squibb Co $59.56 -2.92% 127.29B 13.8 14.6% +1.5% 4.58% Hold Compare
RPRX Royalty Pharma Plc- Cl A $68.67 -0.01% 39.65B 59.1 32.4% +2.1% 2.96% Strong buy Compare
ZTS Zoetis Inc $85.57 +2.50% 32.56B 12.5 28.2% +5.4% 1.64% Hold Compare
VTRS Viatris Inc $20.28 -0.83% 23.30B — -24.6% -4.2% 5.09% Buy Compare
JAZZ Jazz Pharmaceuticals Plc $247.77 +2.93% 15.29B 74.2 -8.4% +5.3% — Strong buy Compare
ELAN Elanco Animal Health Inc $26.70 +3.29% 13.40B — -4.9% +2.3% — Strong buy Compare
CRNX Crinetics Pharmaceuticals In $84.95 +0.13% 9.01B — -6,046.2% +17.5% — Hold Compare
CORT Corcept Therapeutics Inc $67.79 -3.25% 7.85B 48.4 13.1% +23.7% — Strong buy Compare
AMRX Amneal Pharmaceuticals Inc $21.88 +3.60% 7.46B 56.0 2.4% +10.9% — Strong buy Compare
AXSM Axsome Therapeutics Inc $134.00 -1.43% 7.37B — -28.7% +133.7% — Strong buy Compare
LGND Ligand Pharmaceuticals $300.21 +2.18% 6.33B 122.9 46.4% +11.0% — Strong buy Compare
TERN Terns Pharmaceuticals Inc $52.95 +0.00% 6.12B — 32.1% -4.4% — Hold Compare
SUPN Supernus Pharmaceuticals Inc $29.24 +0.69% 6.07B 17.6 29.2% +2.5% — Strong buy Compare
LQDA Liquidia Corp $57.68 +1.67% 5.17B — -43.5% +115.0% — Buy Compare
EWTX Edgewise Therapeutics Inc $41.76 -0.67% 5.03B 5.0 17.7% +16.1% — Strong buy Compare
DFTX Definium Therapeutics Inc $28.88 -1.70% 4.43B — 19.9% -7.8% — Strong buy Compare